Miracle Leaf® medical marijuana guide
Cannabis Drug Interactions: What Actually Matters
Three enzyme systems explain nearly every cannabis drug interaction. Which medications matter, why CBD dose predicts more than THC, and what to ask.
Most medications do not interact with cannabis. The ones that do are not a random list to be memorized, and the useful way to think about the question is not drug by drug at all. Nearly every documented or plausible cannabis drug interaction runs through one of three enzyme systems, and knowing which system a medication depends on answers most of the question before you look anything up.
This page explains the three systems and links to the detailed article for each medication. It is written by the Miracle Leaf® editorial team and reviewed against primary sources.
The three systems
CYP3A4. This is the enzyme that clears THC and CBD themselves. Drugs that strongly inhibit it raise cannabis exposure, and drugs that induce it lower cannabis exposure. This is the one system where the effect runs primarily in that direction, cannabis levels moving rather than the other drug's.
CYP2C9. This clears a number of narrow margin drugs, including NSAIDs such as ibuprofen and the anticoagulant warfarin. Cannabinoids inhibit it, so the concern here is the other drug accumulating.
Glucuronidation, performed by the UGT enzymes. This is the disposal route for acetaminophen and several other common drugs, and it sits outside the cytochrome P450 system entirely. Cannabidiol is a potent inhibitor of several UGT enzymes, and this system is the least discussed of the three.
A fourth category matters and involves no enzymes at all: additive effects. Two drugs that both sedate will sedate more together whether or not either changes the other's blood level. That is the whole story for gabapentin and much of the story for benzodiazepines and alcohol.
Why the cannabidiol number matters more than the THC number
The most useful practical finding across this research is counterintuitive.
In laboratory testing THC is frequently the more potent enzyme inhibitor. In people, cannabidiol is usually the one that produces a measurable effect. The reason is dose rather than potency: cannabidiol products are dosed in hundreds of milligrams while THC products are dosed in tens, and that gap is wide enough to overwhelm the potency difference.
The practical consequence is that if you take a medication and want to know whether your cannabis use is relevant, the number to read off the product label is usually the cannabidiol content. A concentrated cannabidiol tincture taken daily is the profile most likely to matter. A low dose THC product is the profile least likely to.
Route can push an effect in either direction
Oral cannabis passes through the liver before reaching general circulation, which is where most of the enzyme inhibition described above takes place. Inhaled cannabis largely bypasses that first pass.
Smoke adds a second and opposite mechanism. Combustion products induce one enzyme, CYP1A2, rather than inhibiting it, by the same route tobacco smoke does. So for drugs that depend on that enzyme, an edible and a joint would be expected to push in opposite directions. This is not a large effect for most medications, but it means cannabis is not one exposure for these purposes.
The medications, one article each
Each of these covers what has been measured, what has only been inferred, and what nobody has studied.
| Medication | What the article covers |
|---|---|
| Ibuprofen and NSAIDs | CYP2C9. Cannabidiol raised a probe drug's exposure 63 to 77 percent where THC did not |
| Acetaminophen and Tylenol | Glucuronidation. Cannabidiol's strongest UGT target is an enzyme acetaminophen depends on |
| Antibiotics | CYP3A4. Rifampin cut the active THC metabolite by 90 percent. Most antibiotics do nothing |
| Gabapentin | No enzyme at all. Additive sedation, and an FDA breathing warning |
| Adderall and stimulants | CYP2D6 was tested and unaffected. The real question is cardiovascular |
| Antidepressants, SSRIs and SNRIs | Enzyme overlap plus the serotonergic question |
| Xanax and benzodiazepines | Additive CNS depression, and the one real interaction study |
| Alcohol | Co-use, impairment and crash risk |
What is not on this page
Two honest gaps worth stating rather than hiding.
Several very common antibiotics, including amoxicillin, doxycycline and ciprofloxacin, have never been studied with cannabis. They are described in the antibiotics article as unstudied rather than as safe, because those are different claims.
More broadly, the cannabis interaction literature is thin. Systematic reviews of the field cover a limited set of drug classes, and whole categories of common medication have simply never been examined. Where an article on this site states an expectation rather than a measurement, it says so.
What to bring to a certification appointment
The names and doses of everything you take, including over the counter products people often forget to mention, and the cannabidiol and THC milligrams in anything you already use.
A medication list does not determine eligibility. Qualifying in Florida, Georgia or Texas depends on having a qualifying condition. What the list changes is the conversation about route, dose and timing, which is the part a physician can actually help with.
Common questions
Frequently asked questions
Does cannabis interact with most medications?
Which matters more for interactions, THC or CBD?
What are the three enzyme systems that matter?
Do interactions depend on how you consume cannabis?
Will a medication list stop me getting a medical card?
What should I bring to a certification appointment?
Keep reading